Follow
Dominick Angiolillo
Dominick Angiolillo
Verified email at jax.ufl.edu
Title
Cited by
Cited by
Year
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute …
JP Collet, H Thiele, E Barbato, O Barthélémy, J Bauersachs, DL Bhatt, ...
European heart journal 42 (14), 1289-1367, 2021
49742021
Prasugrel compared with high loading-and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel …
SD Wiviott, D Trenk, AL Frelinger, M O’Donoghue, FJ Neumann, ...
Circulation 116 (25), 2923-2932, 2007
1811*2007
Standard-vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial
MJ Price, PB Berger, PS Teirstein, JF Tanguay, DJ Angiolillo, D Spriggs, ...
Jama 305 (11), 1097-1105, 2011
16092011
Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate
L Bonello, US Tantry, R Marcucci, R Blindt, DJ Angiolillo, R Becker, ...
Journal of the American College of Cardiology 56 (12), 919-933, 2010
13522010
Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives
DJ Angiolillo, A Fernandez-Ortiz, E Bernardo, F Alfonso, C Macaya, ...
Journal of the American College of Cardiology 49 (14), 1505-1516, 2007
12292007
Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding
US Tantry, L Bonello, D Aradi, MJ Price, YH Jeong, DJ Angiolillo, ...
Journal of the American College of Cardiology 62 (24), 2261-2273, 2013
9162013
Effect of platelet inhibition with cangrelor during PCI on ischemic events
DL Bhatt, GW Stone, KW Mahaffey, CM Gibson, PG Steg, CW Hamm, ...
New England Journal of Medicine 368 (14), 1303-1313, 2013
8872013
Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk
P Urban, R Mehran, R Colleran, DJ Angiolillo, RA Byrne, D Capodanno, ...
Circulation 140 (3), 240-261, 2019
8442019
Ticagrelor with or without aspirin in high-risk patients after PCI
R Mehran, U Baber, SK Sharma, DJ Cohen, DJ Angiolillo, C Briguori, ...
New England Journal of Medicine 381 (21), 2032-2042, 2019
8152019
Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies
R Moreno, C Fernández, R Hernández, F Alfonso, DJ Angiolillo, M Sabaté, ...
Journal of the American College of Cardiology 45 (6), 954-959, 2005
7862005
A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation …
D Trenk, GW Stone, M Gawaz, A Kastrati, DJ Angiolillo, U Müller, ...
Journal of the American College of Cardiology 59 (24), 2159-2164, 2012
7602012
Platelet inhibition with cangrelor in patients undergoing PCI
RA Harrington, GW Stone, S McNulty, HD White, AM Lincoff, CM Gibson, ...
New England Journal of Medicine 361 (24), 2318-2329, 2009
7322009
Ticagrelor or prasugrel in patients with acute coronary syndromes
S Schüpke, FJ Neumann, M Menichelli, K Mayer, I Bernlochner, J Wöhrle, ...
New England Journal of Medicine 381 (16), 1524-1534, 2019
7302019
Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment
DJ Angiolillo, A Fernandez-Ortiz, E Bernardo, C Ramírez, M Sabaté, ...
Diabetes 54 (8), 2430-2435, 2005
6972005
Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease: results of the Optimizing Antiplatelet Therapy in …
DJ Angiolillo, SB Shoemaker, B Desai, H Yuan, RK Charlton, E Bernardo, ...
Circulation 115 (6), 708-716, 2007
6242007
Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial
S James, DJ Angiolillo, JH Cornel, D Erlinge, S Husted, F Kontny, J Maya, ...
European heart journal 31 (24), 3006-3016, 2010
5442010
Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial
DJ Angiolillo, MS Firstenberg, MJ Price, PE Tummala, M Hutyra, IJ Welsby, ...
Jama 307 (3), 265-274, 2012
5412012
Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trial
KW Mahaffey, DM Wojdyla, K Carroll, RC Becker, RF Storey, DJ Angiolillo, ...
Circulation 124 (5), 544-554, 2011
5152011
Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: a time-dependent analysis of the Gauging Responsiveness with a VerifyNow P2Y12 assay …
MJ Price, DJ Angiolillo, PS Teirstein, E Lillie, SV Manoukian, PB Berger, ...
Circulation 124 (10), 1132-1137, 2011
5102011
Dosing clopidogrel based on CYP2C19 genotype and the effect on platelet reactivity in patients with stable cardiovascular disease
JL Mega, W Hochholzer, AL Frelinger, MJ Kluk, DJ Angiolillo, ...
Jama 306 (20), 2221-2228, 2011
5002011
The system can't perform the operation now. Try again later.
Articles 1–20